Daphne de Jong

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. ncbi request reprint Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium
    Daphne de Jong
    Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 25:805-12. 2007
  2. ncbi request reprint Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors
    Daphne de Jong
    Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Clin Oncol 23:6358-63. 2005
  3. doi request reprint Inflammatory cells and immune microenvironment in malignant lymphoma
    D De Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Intern Med 264:528-36. 2008
  4. pmc Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols
    Daphne de Jong
    Dept of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Haematologica 94:70-7. 2009
  5. ncbi request reprint Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity
    D De Jong
    The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Ann Oncol 17:141-5. 2006
  6. doi request reprint Anaplastic large-cell lymphoma in women with breast implants
    Daphne de Jong
    Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands
    JAMA 300:2030-5. 2008
  7. doi request reprint Predicting transformation in follicular lymphoma
    Daphne de Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Leuk Lymphoma 50:1406-11. 2009
  8. doi request reprint The molecular background of aggressive B cell lymphomas as a basis for targeted therapy
    Daphne de Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Pathol 223:274-82. 2011
  9. doi request reprint Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)
    D De Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Pathol 62:128-38. 2009
  10. doi request reprint The microenvironment in follicular lymphoma
    Daphne de Jong
    The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Best Pract Res Clin Haematol 24:135-46. 2011

Detail Information

Publications46

  1. ncbi request reprint Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium
    Daphne de Jong
    Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 25:805-12. 2007
    ....
  2. ncbi request reprint Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors
    Daphne de Jong
    Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Clin Oncol 23:6358-63. 2005
    ..These insights may lead to improvement of risk stratification, but most importantly will provide tools for developing new targets and strategies for treatment...
  3. doi request reprint Inflammatory cells and immune microenvironment in malignant lymphoma
    D De Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Intern Med 264:528-36. 2008
    ..In this review, the functional interactions and clinical consequences of these insights are discussed in indolent and aggressive B-cell lymphomas and in classical Hodgkin's lymphoma...
  4. pmc Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols
    Daphne de Jong
    Dept of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Haematologica 94:70-7. 2009
    ..The precise nature of the cell populations is still unclear and published data on their prognostic significance are highly conflicting. This may be partly due to heterogeneous composition and treatments...
  5. ncbi request reprint Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity
    D De Jong
    The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Ann Oncol 17:141-5. 2006
    ..To investigate the proportion, clinical characteristics and outcome of lymphocyte-rich classical Hodgkin lymphoma (LRCHL) in relation to nodular lymphocyte predominant HL (NLPHL) and classical HL (cHL)...
  6. doi request reprint Anaplastic large-cell lymphoma in women with breast implants
    Daphne de Jong
    Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands
    JAMA 300:2030-5. 2008
    ..Similar cases have been reported in the literature. Although an increased risk of ALCL in patients with breast prostheses has been speculated, no studies have been conducted so far...
  7. doi request reprint Predicting transformation in follicular lymphoma
    Daphne de Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Leuk Lymphoma 50:1406-11. 2009
    ....
  8. doi request reprint The molecular background of aggressive B cell lymphomas as a basis for targeted therapy
    Daphne de Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Pathol 223:274-82. 2011
    ..In this review, the molecular background and the consequences of the molecular alterations in the context of the consequences for treatment in aggressive B cell lymphoma are discussed...
  9. doi request reprint Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)
    D De Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Pathol 62:128-38. 2009
    ..In this study, an international collaboration of clinical lymphoma research groups has concentrated on validation and standardisation of immunohistochemistry of the currently potentially interesting prognostic markers in DLBCL...
  10. doi request reprint The microenvironment in follicular lymphoma
    Daphne de Jong
    The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Best Pract Res Clin Haematol 24:135-46. 2011
    ..These insights may thoroughly change the therapeutic approaches in FL and translate into programs that combine direct cytotoxic and indirect immunomodulatory aspects...
  11. pmc Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia
    Daphne de Jong
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Pathol 221:242-7. 2010
    ....
  12. doi request reprint Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis
    Ronald S A de Vreeze
    Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Cancer 128:778-86. 2011
    ..For treatment stratification, detailed classification including molecular support should be performed in tumors with heterogeneous MRI features...
  13. pmc Multifocal myxoid liposarcoma--metastasis or second primary tumor?: a molecular biological analysis
    Ronald de Vreeze
    Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Mol Diagn 12:238-43. 2010
    ..This study supports the metastatic nature of apparent multifocal myxoid/round cell liposarcoma...
  14. pmc Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience
    Ronald S A de Vreeze
    Departments of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 17:686-93. 2010
    ..Treatment decisions and prognosis assessment for liposarcoma is based on a classification that depends on morphological and genetic features. Revisions by experienced referral pathologists are often advocated...
  15. doi request reprint Long-term results of stomach-conserving therapy in gastric MALT lymphoma
    Conny Vrieling
    Department of Radiation Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek ziekenhuis, Amsterdam, The Netherlands
    Radiother Oncol 87:405-11. 2008
    ..To evaluate long-term results of stomach-conserving therapy and to assess the value of histological probable minimal residual disease (pMRD) in predicting outcome in patients with gastric MALT lymphoma...
  16. ncbi request reprint In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma
    Laurent Knoops
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Blood 110:1116-22. 2007
    ..Moreover, this study is the first in vivo report of the radiation-induced p53 apoptotic response in patients and suggests that this apoptotic response is not immunologically silent...
  17. doi request reprint Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment
    Jan Paul de Boer
    Department of Medical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Leuk Lymphoma 52:2262-9. 2011
    ..In addition an increase in density of FOXP3 + cells (i.e. Tregs) was seen (p = 0.047). These alterations in different T-cell subsets were not observed in gastric biopsy samples of patients treated with HP-eradication only...
  18. ncbi request reprint Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma
    Annuska M Glas
    Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 25:390-8. 2007
    ..Despite the generally favorable clinical course in follicular lymphoma (FL), a minority of patients have a poor prognosis-with death within 3 years of diagnosis-most often due to transformation to aggressive disease...
  19. ncbi request reprint Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma
    Berthe M P Aleman
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam
    Int J Radiat Oncol Biol Phys 67:19-30. 2007
    ..The purpose of this study was to describe the role of radiotherapy in patients with advanced HL who were in partial remission (PR) after chemotherapy...
  20. doi request reprint Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma
    Rick L M Haas
    Department of Radiotherapy, The Netherlands Cancer Institute Amsterdam, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 74:1199-202. 2009
    ..Considerable discussion is ongoing on the treatment of primary and relapsed disease...
  21. ncbi request reprint Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
    Annuska M Glas
    Netherlands Cancer Institute, Division of Diagnostic Oncology, Central Microarray Facility, Amsterdam, The Netherlands
    Blood 105:301-7. 2005
    ....
  22. pmc Delineation of chondroid lipoma: an immunohistochemical and molecular biological analysis
    Ronald S A de Vreeze
    Department of Surgical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX, Amsterdam, The Netherlands
    Sarcoma 2011:638403. 2011
    ..Conclusions. Chondroid lipoma is extremely rare and has several and more prevalent histological mimics. The differential diagnosis of chondroid lipomas can be unraveled using immunohistochemical and molecular support...
  23. doi request reprint Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern
    Ronald S A de Vreeze
    Department of Surgical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 72:1480-7. 2008
    ..Here we describe our results with preoperative RT and propose a mechanism explaining the high sensitivity based on the distinctive vascularization pattern of MLS...
  24. ncbi request reprint In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients
    Rick L M Haas
    Department of Radiotherapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 59:782-7. 2004
    ..To evaluate (99m)Tc-Annexin-V (TAV) scintigraphy in monitoring radiation-induced apoptotic cell death in follicular lymphoma (FL) patients...
  25. ncbi request reprint Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation
    Margit Schraders
    Department of Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands
    J Pathol 205:329-35. 2005
    ..These findings may have consequences for the use of Bcl-2 immunohistochemistry for diagnostic purposes...
  26. doi request reprint Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Fam Cancer 11:363-9. 2012
    ..National and international collaboration is warranted to improve the quality of research by increasing the size of study cohorts...
  27. doi request reprint An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer
    Ian J Majewski
    Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Pathol 229:621-9. 2013
    ..We also detected somatic mutations in one tumour and found substantial overlap with genes mutated in sporadic gastric cancer, including PIK3CA, ARID1A, MED12 and MED23...
  28. doi request reprint Hereditary causes of kidney tumours
    Priscilla Helene Axwijk
    The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Eur J Clin Invest 40:433-9. 2010
    ..Hereditary renal cancer accounts for about 2-4% of cases. Recognition of this subgroup by clinicians is important because of the possibility of severe medical consequences for patients and their relatives...
  29. doi request reprint Dissemination patterns in non-gastric MALT lymphoma
    Jan Paul de Boer
    Dept of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Haematologica 93:201-6. 2008
    ....
  30. doi request reprint Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients
    Gabe S Sonke
    Departments of 1Medical Oncology and 2Pathology, Antoni van Leeuwenhoek Hospital Netherlands Cancer Institute, 1006 BE Amsterdam, The Netherlands
    Clin Infect Dis 47:105-8. 2008
    ....
  31. doi request reprint CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling
    Irma Kluijt
    Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Int J Cancer 131:367-76. 2012
    ..The relationship between CL/P and CDH1 needs further study to inform future parents from hereditary diffuse gastric cancer (HDGC) families adequately...
  32. doi request reprint Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis
    Ronald S A de Vreeze
    Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Mod Pathol 22:223-31. 2009
    ..Moreover, finding of myxoid/round cell liposarcoma translocations in a retroperitoneal localization is highly suggestive of metastasis and should prompt search for a primary localization outside the retroperitoneum...
  33. doi request reprint Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary
    Hugo M Horlings
    Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 26:4435-41. 2008
    ..Currently, the success rate of the diagnostic work-up is only 20% to 30%. Our goal was to evaluate the contribution of gene expression profiling for routine clinical practice in patients with ACUP...
  34. ncbi request reprint Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents
    Shuraila F Zerp
    Division of Cellular Biochemistry, Department of Pathology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan, CX Amsterdam, The Netherlands
    Anticancer Drugs 19:65-75. 2008
    ..Interference with the angiogenic process represents a novel mode of action of APLs and might significantly contribute to the antitumor effect of these compounds...
  35. ncbi request reprint Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma
    Marleen Kok
    Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Tumour Biol 24:53-60. 2003
    ..A study in a larger cohort of patients is required to validate this approach...
  36. ncbi request reprint Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
    Tom W Geurts
    Department of ORL, Academic Medical Center, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Clin Cancer Res 11:6608-14. 2005
    ..To distinguish a metastasis from a second primary tumor in patients with a history of head and neck squamous cell carcinoma and subsequent pulmonary squamous cell carcinoma...
  37. ncbi request reprint Thallium-201-chloride scintigraphy in staging and monitoring radiotherapy response in follicular lymphoma patients
    Rick L M Haas
    Department of Radiotherapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    Radiother Oncol 69:323-8. 2003
    ..To study thallium-201-chloride scintigraphy (201Tl-S) in staging and monitoring response after radiotherapy in follicular lymphoma (FL) patients...
  38. ncbi request reprint Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features
    Daphne de Jong
    Department of Pathology, Biomedics and Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Blood 102:324-7. 2003
    ..5 years (P =.005). In conclusion, we have found evidence that late-relapsing DLBCL represents truly clonally related disease episodes in most cases and that this clinical behavior may be related to the biologic features of GC cells...
  39. pmc Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
    Richard J Bende
    Department of Pathology, Academic Medical Center, Netherlands Cncer Institute, 1105 AZ Amsterdam, The Netherlands
    J Exp Med 201:1229-41. 2005
    ..Interestingly, RF-CDR3 homology and t(11;18) appeared to be mutually exclusive features and RF-CDR3 homology was not encountered in any of the 19 pulmonary MALT lymphomas studied...
  40. ncbi request reprint Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy
    Natascha Verra
    Department of Immunology, Netherlands Cancer Institute, Amsterdam
    Eur Urol 48:527-33. 2005
    ..Main goals were to determine the maximal tolerable dose and detailed in situ analysis of tumor infiltrates...
  41. ncbi request reprint T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication
    Hongxiang Liu
    Department of Histopathology, University College London, London, England
    Gastroenterology 122:1286-94. 2002
    ..pylori eradication. The present study aimed to verify this finding in a large cohort and confirm whether the translocation predicts the response of stage I(E) tumors, for which clinical staging has little prognostic value...
  42. pmc Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival
    Catherine Thieblemont
    Leuk Lymphoma 49:1403-6. 2008
  43. ncbi request reprint The microarray way to tailored cancer treatment
    Laura J van 't Veer
    Nat Med 8:13-4. 2002
  44. ncbi request reprint Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma
    Marije Booman
    Department of Pathology and Laboratory Medicine, University Medical Center Groningen, Groningen, Netherlands
    Clin Cancer Res 12:2698-705. 2006
    ....
  45. ncbi request reprint The role of the p53 pathway in the treatment of follicular lymphoma
    Laurent Knoops
    Experimental Medicine Unit, de Duve Institute, Universite Catholique de Louvain, Brussels, Belgium
    Cell Cycle 7:436-9. 2008
    ..These insights have implications for the design of new protocols in the treatment of follicular lymphoma...
  46. pmc Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia
    Shelly R Gunn
    The University of Texas Health Science Center at San Antonio, Department of Pathology, Mail Code 7750, 7703 Floyd Curl Dr, San Antonio, TX, USA
    J Mol Diagn 10:442-51. 2008
    ..5%); 13 hybridizations (4.5%) were discordant because of clonal populations that comprised less than 30% of the sample. Array CGH is a powerful, cost-effective tool for genome-wide risk assessment in the clinical evaluation of CLL...